Sanofi SA header image

Sanofi SA

SAN

Equity

ISIN FR0000120578 / Valor 699381

Euronext - Euronext Paris (2026-10-23)
EUR 74.12-1.11%

Sanofi SA
UMushroom community rating:

star star star star star
4.50 2 votes No rating yet
NegativeNeutralPositive

About company

Sanofi SA is a Paris‑based multinational pharmaceutical company that researches, develops, manufactures and markets prescription medicines, vaccines and specialty therapies across a broad range of disease areas including immunology and inflammation, rare diseases, oncology, diabetes and cardiovascular conditions. Its vaccines division, Sanofi Pasteur, is one of the world’s large vaccine manufacturers, and the company’s portfolio spans small molecules and biologics — notably its collaboration with Regeneron on the immunology drug Dupixent — alongside an established insulin franchise. Sanofi combines internal R&D with partnerships and recent investments in platforms such as mRNA, operates global manufacturing and commercial networks, and is publicly traded on Euronext Paris.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-14.4%1Y
-24.6%3Y
-12.9%5Y

Performance

22.9%1Y
25.3%3Y
24.1%5Y

Volatility

Market cap

99473 M

Market cap (USD)

Daily traded volume (Shares)

1,742,949

Daily traded volume (Shares)

1 day high/low

93.83 / 92.97

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.50

2 votes
Performance:
starstarstarstarstar
4.00
Innovation:
starstarstarstarstar
5.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Hubert Joo
Spain, 15 Dec 2025
star star star star star
Sanofi is a solid global pharmaceutical company with a strong focus on biopharma, vaccines, and immunology. It stands out for its innovation capacity, robust pipeline, and stable cash flow generation. A defensive, well-managed long-term investment.
Jules Robin
UK, 22 Oct 2025
star star star star star
Steady growth

EQUITIES OF THE SAME SECTOR

Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals Inc Syndax Pharmaceuticals Inc Valor: 24112479
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.25%USD 13.40
Medartis Holding AG
Medartis Holding AG Medartis Holding AG Valor: 38620023
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
2.73%CHF 94.20
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.46%SEK 300.00
CorVel Corp
CorVel Corp CorVel Corp Valor: 921843
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.01%USD 83.87
Insmed Inc
Insmed Inc Insmed Inc Valor: 12614415
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.76%USD 93.39
Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc Valor: 56295735
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.28%USD 36.13
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.07%USD 28.07
Galapagos NV
Galapagos NV Galapagos NV Valor: 2130343
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.88%EUR 28.14
Inventiva SA
Inventiva SA Inventiva SA Valor: 35598121
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.45%EUR 3.06
Merck KGaA
Merck KGaA Merck KGaA Valor: 412799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.08%EUR 143.30